unither.com (UTHR) Quarterly EPS earnings growth

Symbol and logo of brand United Therapeutics Inc. (UTHR)

Despite geopolitical supply chain risks and patent disputes, United Therapeutics maintains a staff of leading scientists, preventing talent attrition. The quarterly earnings per share growth rate serves as a stability indicator, where the value -20.10 confirms the current level. The business capitalization is based on the commercialization of innovative therapies for rare cardiovascular pathologies and pulmonary hypertension.

UTHR: United Therapeutics Corporation Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/17/2026

United Therapeutics (UTHR) - metric breakdowns and financial figures

- share price and expert price forecast:
Initial company analysis:United Therapeutics
Flagship merchandise of United Therapeutics Inc.

United Therapeutics dominates the orphan disease therapy segment, possessing exceptional pricing power. Quarterly EPS dynamics measure the growth rate of net income per share, separating systemic development from random market fluctuations. Comparing quarterly EPS allows investors to verify the stability of cash flows. The positive vector of this metric confirms the effectiveness of the monopoly strategy. A steady trend proves the fundamental strength of the business.

Who United Therapeutics competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Inc. (ALNY)|INSM (Insmed) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months BMRN (BioMarin)|Year-over-year net earnings per share growth for the last 12 months BBIO (BridgeBio)|BGM: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Year-over-year net earnings per share trend for the last twelve months|Keros Therapeutics - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months ARCT (Arcturus Therapeutics)|ETON: Quarterly EPS earnings growth|Kamada Ltd (KMDA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Fulcrum Tx|ABEO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Mereo BioPharma Group (MREO)|Quarterly EPS earnings growth protalix.com (PLX)|Quarterly EPS earnings growth PLRX (Pliant Therapeutics Inc)|Quarterly EPS earnings growth Applied Therapeutics APLT|RNTX - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Year-over-year net earnings per share growth for the last 12 months|Chemomab Therapeutics Ltd - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SRXH|Year-over-year earnings per share growth for the last twelve months PLRZ|Quarterly EPS earnings growth AEZS|Year-over-year earnings per share growth for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Year-over-year net earnings per share growth for the last 12 months|Reneo Pharmaceuticals, Inc. (RPHM) - Earnings per share growth in annualized terms for the last twelve months|COSCIENS Bio - Quarterly EPS earnings growth